FIELD: medicine.SUBSTANCE: invention relates to medicine, namely to cardiology, psychiatry and medical psychology, and can be used for prediction of efficiency of pharmacological correction of psychosomatic disorders in women in postmenaopausal period with arterial hypertension. Results of psychometric scales and questionnaires during the first visit: hospital scale of anxiety and depression HADS, Spielberger questionnaire, questionnaire for identification of signs of vegetative changes, scale of asthenic state (SAS), short scale of psychic status estimation (SSPSE), visual-analogous scale for estimation of expression of dream disturbance, "HAM" test. Coefficient of efficiency Cef is determined by means of the following equation: Cef=12.2677-0.00679756*age -0.158645*anxiety - 0.102177* depression+0.00839559* situation anxiety - 0.0124299* personality anxiety - 0.0240099* - vegetative disorders - 0.00929817* asthenia -0.195727* cognitive sphere - 0.00576782* dream disturbances + 0.0286554* health-0.0142442*activity - 0.00360372*mood. If coefficient is lower than 3.1 presumed efficiency of treatment with adaptol is estimated as low. If Cef is from 3.2 to 3.7, presumed efficiency of treatment with adaptol is estimated as satisfactory. If Cef is higher than 3.7, presumed efficiency of treatment with adaptol is estimated as high.EFFECT: method makes it possible to ensure creation of diagnostic criterion for prediction of adaptol application efficiency in women in postmenopausal period with arterial hypertension in case of identification of psychosomatic disorders by testing.2 exИзобретение относится к медицине, а именно к кардиологии, психиатрии и медицинской психологии, и может быть использовано для прогноза эффективности фармакологической коррекции психосоматических нарушений у женщин в постменопаузе с артериальной гипертензией. Используют результаты психометрических шкал и опросников при первичном обращении: госпитальной шкалы тревоги и депрессии HADS, опросника Спилб
